68 related articles for article (PubMed ID: 21245102)
1. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
Huang M; Inukai T; Miyake K; Tanaka Y; Kagami K; Abe M; Goto H; Minegishi M; Iwamoto S; Sugihara E; Watanabe A; Somazu S; Shinohara T; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2018 Apr; 7(4):1297-1316. PubMed ID: 29473342
[TBL] [Abstract][Full Text] [Related]
2. Human Biodistribution and Radiation Dosimetry of
Barrio MJ; Spick C; Radu CG; Lassmann M; Eberlein U; Allen-Auerbach M; Schiepers C; Slavik R; Czernin J; Herrmann K
J Nucl Med; 2017 Mar; 58(3):374-378. PubMed ID: 27811125
[No Abstract] [Full Text] [Related]
3. 4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.
Calbert ML; Chandramouly G; Adams CM; Saez-Ayala M; Kent T; Tyagi M; Ayyadevara VSSA; Wang Y; Krais JJ; Gordon J; Atkins J; Toma MM; Betzi S; Boghossian AS; Rees MG; Ronan MM; Roth JA; Goldman AR; Gorman N; Mitra R; Childers WE; Graña X; Skorski T; Johnson N; Hurtz C; Morelli X; Eischen CM; Pomerantz RT
Mol Cancer Ther; 2024 May; 23(5):683-699. PubMed ID: 38064712
[TBL] [Abstract][Full Text] [Related]
4. Targeting host deoxycytidine kinase mitigates
Winstel V; Abt ER; Le TM; Radu CG
bioRxiv; 2023 Dec; ():. PubMed ID: 37645972
[TBL] [Abstract][Full Text] [Related]
5. Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response.
Kamath A; Srinivasamurthy SK; Chowta MN; Ullal SD; Daali Y; Chakradhara Rao US
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015138
[TBL] [Abstract][Full Text] [Related]
6. Is Monitoring of the Intracellular Active Metabolite Levels of Nucleobase and Nucleoside Analogs Ready for Precision Medicine Applications?
Huang S; Bian Y; Huang C; Miao L
Eur J Drug Metab Pharmacokinet; 2022 Nov; 47(6):761-775. PubMed ID: 35915365
[TBL] [Abstract][Full Text] [Related]
7. Semi-Automated High-Throughput Substrate Screening Assay for Nucleoside Kinases.
Hellendahl KF; Fehlau M; Hans S; Neubauer P; Kurreck A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768989
[TBL] [Abstract][Full Text] [Related]
8. One ring to bring them all and in the darkness bind them: The trafficking of heme without deliverers.
Chambers IG; Willoughby MM; Hamza I; Reddi AR
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118881. PubMed ID: 33022276
[TBL] [Abstract][Full Text] [Related]
9. S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is Not a Selective Inhibitor of Equilibrative Nucleoside Transporters but Also Blocks Efflux Activity of Breast Cancer Resistance Protein.
Karbanova S; Sorf A; Jiraskova L; Lalinska A; Ptackova Z; Staud F; Cerveny L
Pharm Res; 2020 Feb; 37(3):58. PubMed ID: 32086630
[TBL] [Abstract][Full Text] [Related]
10. ABCG2 requires a single aromatic amino acid to "clamp" substrates and inhibitors into the binding pocket.
Gose T; Shafi T; Fukuda Y; Das S; Wang Y; Allcock A; Gavan McHarg A; Lynch J; Chen T; Tamai I; Shelat A; Ford RC; Schuetz JD
FASEB J; 2020 Apr; 34(4):4890-4903. PubMed ID: 32067270
[TBL] [Abstract][Full Text] [Related]
11. Antileukemic activity of novel adenosine derivatives.
Poczta A; Rogalska A; Łukawska M; Marczak A
Sci Rep; 2019 Oct; 9(1):14135. PubMed ID: 31575977
[TBL] [Abstract][Full Text] [Related]
12. Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen.
Windt T; Tóth S; Patik I; Sessler J; Kucsma N; Szepesi Á; Zdrazil B; Özvegy-Laczka C; Szakács G
Arch Toxicol; 2019 Apr; 93(4):953-964. PubMed ID: 30863990
[TBL] [Abstract][Full Text] [Related]
13. Clofarabine Has Apoptotic Effect on T47D Breast Cancer Cell Line via P53R2 Gene Expression.
Rahmati-Yamchi M; Zarghami N; Nozad Charoudeh H; Ahmadi Y; Baradaran B; Khalaj-Kondori M; Milani M; Akbarzadeh A; Shaker M; Pourhassan-Moghaddam M
Adv Pharm Bull; 2015 Nov; 5(4):471-6. PubMed ID: 26819918
[TBL] [Abstract][Full Text] [Related]
14. New insights into the synergism of nucleoside analogs with radiotherapy.
Lee MW; Parker WB; Xu B
Radiat Oncol; 2013 Sep; 8():223. PubMed ID: 24066967
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus protease inhibitors interact with ATP binding cassette transporter 4/multidrug resistance protein 4: a basis for unanticipated enhanced cytotoxicity.
Fukuda Y; Takenaka K; Sparreboom A; Cheepala SB; Wu CP; Ekins S; Ambudkar SV; Schuetz JD
Mol Pharmacol; 2013 Sep; 84(3):361-71. PubMed ID: 23775562
[TBL] [Abstract][Full Text] [Related]
16. The role of transporters in the toxicity of nucleoside and nucleotide analogs.
Koczor CA; Torres RA; Lewis W
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):665-76. PubMed ID: 22509856
[TBL] [Abstract][Full Text] [Related]
17. ABC transporters and their role in nucleoside and nucleotide drug resistance.
Fukuda Y; Schuetz JD
Biochem Pharmacol; 2012 Apr; 83(8):1073-83. PubMed ID: 22285911
[TBL] [Abstract][Full Text] [Related]
18. Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.
Nagai S; Takenaka K; Nachagari D; Rose C; Domoney K; Sun D; Sparreboom A; Schuetz JD
Cancer Res; 2011 Mar; 71(5):1781-91. PubMed ID: 21245102
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.
de Wolf C; Jansen R; Yamaguchi H; de Haas M; van de Wetering K; Wijnholds J; Beijnen J; Borst P
Mol Cancer Ther; 2008 Sep; 7(9):3092-102. PubMed ID: 18765824
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
